| [1] |
YANG X, LI Q, LIU WT, et al. Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: From pathogenesis to treatment[J]. Cell Mol Immunol, 2023, 20( 6): 583- 599. DOI: 10.1038/s41423-023-00983-5. |
| [2] |
HUANG DQ, TERRAULT NA, TACKE F, et al. Global epidemiology of cirrhosis-aetiology, trends and predictions[J]. Nat Rev Gastroenterol Hepatol, 2023, 20( 6): 388- 398. DOI: 10.1038/s41575-023-00759-2. |
| [3] |
ORNOS ED, MURILLO KJ, ONG JP. Liver diseases: Perspective from the Philippines[J]. Ann Hepatol, 2023, 28( 3): 101085. DOI: 10.1016/j.aohep.2023.101085. |
| [4] |
ZHANG WB, FAN WL, GUO J, et al. Osmotic stress activates RIPK3/MLKL-mediated necroptosis by increasing cytosolic pH through a plasma membrane Na +/H + exchanger[J]. Sci Signal, 2022, 15( 734): eabn5881. DOI: 10.1126/scisignal.abn5881. |
| [5] |
|
| [6] |
ANNIBALDI A, MEIER P. Checkpoints in TNF-induced cell death: Implications in inflammation and cancer[J]. Trends Mol Med, 2018, 24( 1): 49- 65. DOI: 10.1016/j.molmed.2017.11.002. |
| [7] |
TING AT, BERTRAND MJM. More to life than NF-κB in TNFR1 signaling[J]. Trends Immunol, 2016, 37( 8): 535- 545. DOI: 10.1016/j.it.2016.06.002. |
| [8] |
ZHANG YY, SU SS, ZHAO SB, et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome[J]. Nat Commun, 2017, 8: 14329. DOI: 10.1038/ncomms14329. |
| [9] |
WEI S, ZHOU HM, WANG Q, et al. RIP3 deficiency alleviates liver fibrosis by inhibiting ROCK1-TLR4-NF-κB pathway in macrophages[J]. FASEB J, 2019, 33( 10): 11180- 11193. DOI: 10.1096/fj.201900752R. |
| [10] |
ROYCHOWDHURY S, MCCULLOUGH RL, SANZ-GARCIA C, et al. Receptor interacting protein 3 protects mice from high-fat diet-induced liverinjury[J]. Hepatology, 2016, 64( 5): 1518- 1533. DOI: 10.1002/hep.28676. |
| [11] |
WU XQ, POULSEN KL, SANZ-GARCIA C, et al. MLKL-dependent signaling regulates autophagic flux in a murine model of non-alcohol-associated fatty liver and steatohepatitis[J]. J Hepatol, 2020, 73( 3): 616- 627. DOI: 10.1016/j.jhep.2020.03.023. |
| [12] |
MAJDI A, AOUDJEHANE L, RATZIU V, et al. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease[J]. J Hepatol, 2020, 72( 4): 627- 635. DOI: 10.1016/j.jhep.2019.11.008. |
| [13] |
SCHUPPAN D, SURABATTULA R, WANG XY. Determinants of fibrosis progression and regression in NASH[J]. J Hepatol, 2018, 68( 2): 238- 250. DOI: 10.1016/j.jhep.2017.11.012. |
| [14] |
KOSCHEL J, NISHANTH G, JUST S, et al. OTUB1 prevents lethal hepatocyte necroptosis through stabilization of c-IAP1 during murine liver inflammation[J]. Cell Death Differ, 2021, 28( 7): 2257- 2275. DOI: 10.1038/s41418-021-00752-9. |
| [15] |
MOHAMMED S, THADATHIL N, SELVARANI R, et al. Necroptosis contributes to chronic inflammation and fibrosis in aging liver[J]. Aging Cell, 2021, 20( 12): e13512. DOI: 10.1111/acel.13512. |
| [16] |
ZHANG BC, LI MD, YIN RN, et al. O-GlcNAc transferase suppresses necroptosis and liver fibrosis[J]. JCI Insight, 2019, 4( 21): e127709. DOI: 10.1172/jci.insight.127709. |
| [17] |
LIU Q, LEI XH, CAO ZY, et al. TRPM8 deficiency attenuates liver fibrosis through S100A9-HNF4α signaling[J]. Cell Biosci, 2022, 12( 1): 58. DOI: 10.1186/s13578-022-00789-4. |
| [18] |
ZHOU J, ZHAO Y, GUO YJ, et al. A rapid juvenile murine model of nonalcoholic steatohepatitis(NASH): Chronic intermittent hypoxia exacerbates Western diet-induced NASH[J]. Life Sci, 2021, 276: 119403. DOI: 10.1016/j.lfs.2021.119403. |
| [19] |
GUERRA S, MOCCIARO G, GASTALDELLI A. Adipose tissue insulin resistance and lipidome alterations as the characterizing factors of non-alcoholic steatohepatitis[J]. Eur J Clin Invest, 2022, 52( 3): e13695. DOI: 10.1111/eci.13695. |
| [20] |
GUO R, JIA XH, DING ZB, et al. Loss of MLKL ameliorates liver fibrosis by inhibiting hepatocyte necroptosis and hepatic stellate cell activation[J]. Theranostics, 2022, 12( 11): 5220- 5236. DOI: 10.7150/thno.71400. |
| [21] |
HUANG J, LI RB, WANG CB. Molecular mechanism of UPRmt in ameliorating alcohol-induced hepatocyte necroptosis[J]. Acad J Chin PLA Med Sch, 2023, 44( 6): 700- 707. DOI: 10.3969/j.issn.2095-5227.2023.06.020. |
| [22] |
JIA Y, WANG FX, GUO Q, et al. Curcumol induces RIPK1/RIPK3 complex-dependent necroptosis via JNK1/2-ROS signaling in hepatic stellate cells[J]. Redox Biol, 2018, 19: 375- 387. DOI: 10.1016/j.redox.2018.09.007. |
| [23] |
OH JH, SAEED WK, KIM HY, et al. Hepatic stellate cells activate and avoid death under necroptosis stimuli: Hepatic fibrosis during necroptosis[J]. J Gastroenterol Hepatol, 2023, 38( 12): 2206- 2214. DOI: 10.1111/jgh.16368. |
| [24] |
NOVO E, MARRA F, ZAMARA E, et al. Overexpression of Bcl-2 by activated human hepatic stellate cells: Resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans[J]. Gut, 2006, 55( 8): 1174- 1182. DOI: 10.1136/gut.2005.082701. |
| [25] |
LU CF, XU WX, ZHANG F, et al. Study of Dihydroartemisinin on inducing necroptosis through activating Nrf2 in hepatic stellate cells in vitro[J]. China J Tradit Chin Med Pharm, 2016, 31( 5): 1919- 1925.
陆春风, 许文萱, 张峰, 等. 双氢青蒿素通过激活Nrf2促进肝星状细胞坏死性凋亡的研究[J]. 中华中医药杂志, 2016, 31( 5): 1919- 1925.
|
| [26] |
SUN SM, HUAN S, LI ZH, et al. Curcumol alleviates liver fibrosis by inducing endoplasmic reticulum stress-mediated necroptosis of hepatic stellate cells through Sirt1/NICD pathway[J]. Peer J, 2022, 10: e13376. DOI: 10.7717/peerj.13376. |
| [27] |
KISSELEVA T, BRENNER D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18( 3): 151- 166. DOI: 10.1038/s41575-020-00372-7. |
| [28] |
HU MY, WANG Y, LIU ZS, et al. Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis[J]. Nat Nanotechnol, 2021, 16( 4): 466- 477. DOI: 10.1038/s41565-020-00836-6. |
| [29] |
WU XQ, FAN XD, MCMULLEN MR, et al. Macrophage-derived MLKL in alcohol-associated liver disease: Regulation of phagocytosis[J]. Hepatology, 2023, 77( 3): 902- 919. DOI: 10.1002/hep.32612. |
| [30] |
GAUTHERON J, VUCUR M, REISINGER F, et al. A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis[J]. EMBO Mol Med, 2014, 6( 8): 1062- 1074. DOI: 10.15252/emmm.201403856. |
| [31] |
NI Y, LI JM, LIU MK, et al. Pathological process of liver sinusoidal endothelial cells in liver diseases[J]. World J Gastroenterol, 2017, 23( 43): 7666- 7677. DOI: 10.3748/wjg.v23.i43.7666. |
| [32] |
POISSON J, LEMOINNE S, BOULANGER C, et al. Liver sinusoidal endothelial cells: Physiology and role in liver diseases[J]. J Hepatol, 2017, 66( 1): 212- 227. DOI: 10.1016/j.jhep.2016.07.009. |
| [33] |
LAFOZ E, RUART M, ANTON A, et al. The endothelium as a driver of liver fibrosis and regeneration[J]. Cells, 2020, 9( 4): 929. DOI: 10.3390/cells9040929. |
| [34] |
YAN ML, LI H, XU SY, et al. Targeting endothelial necroptosis disrupts profibrotic endothelial-hepatic stellate cells crosstalk to alleviate liver fibrosis in nonalcoholic steatohepatitis[J]. Int J Mol Sci, 2023, 24( 14): 11313. DOI: 10.3390/ijms241411313. |
| [35] |
ZHENG F, DEVOOGDT N, SPARKES A, et al. Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm[J]. Immunobiology, 2015, 220( 2): 200- 209. DOI: 10.1016/j.imbio.2014.09.018. |
| [36] |
LI JX, FENG JM, WANG Y, et al. The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury[J]. Cell Death Dis, 2014, 5( 6): e1278. DOI: 10.1038/cddis.2014.241. |
| [37] |
WANG SG, NI HM, DORKO K, et al. Increased hepatic receptor interacting protein kinase 3 expression due to impaired proteasomal functions contributes to alcohol-induced steatosis and liver injury[J]. Oncotarget, 2016, 7( 14): 17681- 17698. DOI: 10.18632/oncotarget.6893. |
| [38] |
GÜNTHER C, HE GW, KREMER AE, et al. The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis[J]. J Clin Invest, 2016, 126( 11): 4346- 4360. DOI: 10.1172/JCI87545. |
| [39] |
LIM EJ, KHOBAR KE, CHIN R, et al. Hepatitis C virus-induced hepatocyte cell death and protection by inhibition of apoptosis[J]. J Gen Virol, 2014, 95( Pt 10): 2204- 2215. DOI: 10.1099/vir.0.065862-0. |
| [40] |
HUANG LJ, MAO DW, ZHANG RZ, et al. Research advances in traditional Chinese medicine regulation of programmed cell death in intervening against hepatic fibrosis[J]. J Clin Hepatol, 2024, 40( 1): 161- 168. DOI: 10.12449/JCH240127. 黄良江, 毛德文, 张荣臻, 等. 中医药调控程序性细胞死亡干预肝纤维化的研究进展[J]. 临床肝胆病杂志, 2024, 40( 1): 161- 168. DOI: 10.12449/JCH240127. |
DownLoad: